BCL2 and cancer: In human breast MCF-7 cancer cells, our studies clearly show that stabilization of bcl2 protein by induction of wt53 protein by ·NO/·NO-derived species induces significant resistance to CPT, an important clinical drug for treatment of a wide variety of solid tumors.